// App-Quantinova.ai

OC 56.4 : Targeted panel sequencing for identifying new rare genetic variants associated with venous thromboembolism (VTE): application to 128 patients with unprovoked VTE and negative thrombophilia screening

Researchers

Presenter

  • P. Suchon

Principal Investigators

  • N. Saut

  • D. Tregouet

  • P. Morange

Medical Centers

  • Aix Marseille Univ, INSERM, INRAE, C2VN, Marseille, France; Laboratory of Haematology, La Timone Hospital, Marseille, France, marseille, Provence-Alpes-Cote d'Azur, France

  • Laboratory of Haematology, La Timone Hospital, Marseille, France, marseille, Provence-Alpes-Cote d'Azur, France

  • Aix Marseille Université, Marseille Cedex 9, Provence-Alpes-Cote d'Azur, France

  • University Bordeaux, INSERM UMR 1219, Bordeaux Population Health Research Center, Bordeaux, Aquitaine, France

  • C2VN, INRAE, INSERM Aix-Marseille University, Marseille, Provence-Alpes-Cote d'Azur, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Transcription factor Maf

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved